PGR and breast cancer: From the clinical point of view, BC can be classified according to the immunohistochemistry/fluorescence in situ hybridization (IHC/FISH) profile and divided on the basis of the presence of estrogen receptor (ER), progesterone receptor (PR), and HER2.